Yep. Jon Rapporport writes extensively about this www.nomorefakenews.com.
RFK Jr refers to it in his Fauci book. The remarkable thing about RFK's book is how it excoriates so many public figures, yet it remains unchallenged.
Excerpts from Chapter 4: THE PANDEMIC TEMPLATE: AIDS AND AZT
“Doctors need three qualifications: to be able to lie and not get caught, to pretend to be honest, and to cause death without remorse.” —Jean Froissart 1337–1405
The AZT approval process was a shakedown cruise for Tony Fauci. As he ran AZT around the regulatory traps, Dr. Fauci pioneered and perfected the retinue of corrupt, deceitful, and bullying practices and strategies that he would replicate again and again over the next thirty-three years, to transform NIAID into a drug development dynamo.
When Dr. Fauci entered the principal investigator (PI) drug-testing universe, only one pharmaceutical company, Burroughs Wellcome (predecessor to GlaxoSmithKline), had a drug candidate teed up to test as an AIDS remedy—a toxic concoction, azidothymidine, known popularly as “AZT.
AZT proved to be an irresistible opportunity for Fauci. After all, Burroughs Wellcome not only had a head start in the AIDS drug program, the company also had its own army of veteran “principal investigators” (PIs) with plenty of expertise at running the complex regulatory hurdles—which Dr. Fauci had not yet mastered.
Dr. Fauci needed a visible success to jump-start his program and anoint his new regime with the patina of competence. Nussbaum described how the British pharmaceutical company manipulated its leverage over Dr. Fauci to gain monopoly control over the government’s HIV response:
"Wellcome’s PIs came to dominate NIAID’s clinical trial system. They formed a web linking Wellcome, the drug AZT, and the NIH. They came to sit on the institute’s key drug selection committee, and they voted on whether to give high or low priority to the testing of each anti-AIDS drug, including those that might possibly compete with AZT in the marketplace. The PIs were a power unto themselves. They were, in fact, out of control.”
Dr. Fauci would later mimic this successful model to populate key drug and vaccine approval committees in FDA, CDC, and at the Institute of Medicine (IOM) with his Pharma PIs, giving him, and his Pharma partners, complete, vertically integrated control over the drug approval process from molecule to market.
. . . And so here we are with COVID and the mRNA jabs.
![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png)
branchandroot
Re: Long term sickness
Date: 2022-11-17 11:30 pm (UTC)RFK Jr refers to it in his Fauci book. The remarkable thing about RFK's book is how it excoriates so many public figures, yet it remains unchallenged.
Excerpts from Chapter 4: THE PANDEMIC TEMPLATE: AIDS AND AZT
“Doctors need three qualifications: to be able to lie and not get caught, to pretend to be honest, and to cause death without remorse.” —Jean Froissart 1337–1405
The AZT approval process was a shakedown cruise for Tony Fauci. As he ran AZT around the regulatory traps, Dr. Fauci pioneered and perfected the retinue of corrupt, deceitful, and bullying practices and strategies that he would replicate again and again over the next thirty-three years, to transform NIAID into a drug development dynamo.
When Dr. Fauci entered the principal investigator (PI) drug-testing universe, only one pharmaceutical company, Burroughs Wellcome (predecessor to GlaxoSmithKline), had a drug candidate teed up to test as an AIDS remedy—a toxic concoction, azidothymidine, known popularly as “AZT.
AZT proved to be an irresistible opportunity for Fauci. After all, Burroughs Wellcome not only had a head start in the AIDS drug program, the company also had its own army of veteran “principal investigators” (PIs) with plenty of expertise at running the complex regulatory hurdles—which Dr. Fauci had not yet mastered.
Dr. Fauci needed a visible success to jump-start his program and anoint his new regime with the patina of competence. Nussbaum described how the British pharmaceutical company manipulated its leverage over Dr. Fauci to gain monopoly control over the government’s HIV response:
"Wellcome’s PIs came to dominate NIAID’s clinical trial system. They formed a web linking Wellcome, the drug AZT, and the NIH. They came to sit on the institute’s key drug selection committee, and they voted on whether to give high or low priority to the testing of each anti-AIDS drug, including those that might possibly compete with AZT in the marketplace. The PIs were a power unto themselves. They were, in fact, out of control.”
Dr. Fauci would later mimic this successful model to populate key drug and vaccine approval committees in FDA, CDC, and at the Institute of Medicine (IOM) with his Pharma PIs, giving him, and his Pharma partners, complete, vertically integrated control over the drug approval process from molecule to market.
. . . And so here we are with COVID and the mRNA jabs.